Drug Shortage Report for TARO-SUMATRIPTAN
Report ID | 174809 |
Drug Identification Number | 02361698 |
Brand name | TARO-SUMATRIPTAN |
Common or Proper name | SUMATRIPTAN |
Company Name | TARO PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | SUMATRIPTAN |
Strength(s) | 6MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | 2 |
ATC code | N02CC |
ATC description | ANTIMIGRAINE PREPARATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-11-07 |
Estimated end date | 2023-01-13 |
Actual end date | 2023-01-11 |
Shortage status | Resolved |
Updated date | 2023-01-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2023-01-19 | French | Compare |
v9 | 2023-01-19 | English | Compare |
v8 | 2023-01-10 | French | Compare |
v7 | 2023-01-10 | English | Compare |
v6 | 2022-12-12 | French | Compare |
v5 | 2022-12-12 | English | Compare |
v4 | 2022-11-24 | French | Compare |
v3 | 2022-11-24 | English | Compare |
v2 | 2022-11-15 | French | Compare |
v1 | 2022-11-15 | English | Compare |
Showing 1 to 10 of 10